Congress Program
17:30
Welcome from Congress Chair
Prof Jacob Schachter, Chairman of the Ella Lemelbaum Institute for Immuno-Oncology & Melanoma at the Sheba Medical Center, Israel
17:31
IO/IO Combinations Across Indication Rational and Preliminary Results
Prof Jacob Schachter, Ella Lemelbaum Institute for Immuno-Oncology & Melanoma, Sheba Medical Center, Israel
Followed by Q&A.
Sponsored by 
18:00
Adjuvant Therapy –Lessons from Melanoma
Dr Guy Ben-Betzalel, Ella Lemelbaum Institute for Immuno-Oncology & Melanoma, Sheba Medical Center, Israel
Followed by Q&A
Sponsored by 
18:30
Management of Melanoma Patients Treated with Targeted Therapy
Dr Nethanel Asher, Ella Lemelbaum Institute for Immuno-Oncology & Melanoma, Sheba Medical Center, Israel
Followed by Q&A
Sponsored by 
19:00
New Horizon in Cancer Treatment - Pan Tumor Immunotherapy Combinations
Dr Ronnie Shapira, Ella Lemelbaum Institute for Immuno-Oncology & Melanoma, Sheba Medical Center, Israel
Followed by Q&A.
Sponsored by 
19:30
The Obstacles - Resistance and More
Dr Marco Donia, Copenhagen University Hospital, Denmark
Followed by Q&A
20:00
The Role of Immunotherapy in the Treatment of cSCC
Dr Nethanel Asher, Ella Lemelbaum Institute for Immuno-Oncology & Melanoma, Sheba Medical Center, Israel
Followed by Q&A
Sponsored by
20:30
Case Studies
Presented by Prof Jacob Schachter and team, Ella Lemelbaum Institute for Immuno-Oncology & Melanoma, Sheba Medical Center, Israel